Big Pharma is investing heavily in AI to slash development timelines and foster innovation. But instead of strengthening future relationships with the biotech world, the investment may position ...

Biotech companies create drugs from living organisms, requiring a BLA for FDA approval. Pharma companies develop drugs from chemicals, needing an NDA for FDA approval. Many firms blend biotech and ...

As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news. Investors clearly took the latter more to heart ...

In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against other most profitable biotech stocks to buy right now. With improved market ...

That is essentially the idea behind Roivant ROIV-0.64%decrease; red down pointing triangle, a biotech company with a handful of drugs it got from pharma’s dustbin. Roivant was founded by the ...

Bloomberg Intelligence’s team of experienced biotech, pharma, policy and litigation analysts author exclusive, data-driven research that can help you pinpoint long-term market opportunities.

Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 million IPO. The China-based biotech was formed in 2018 by Ascendis ...